MCRB
Seres Therapeutics Inc
2.90$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | – | 376.7% | 278.7% | 339.5% | 232.3% | 272.7% | 97.9% | 14.1% | 15.3% | – | 523.8% | |
| – | – | – | – | -276.7% | -178.7% | 100.0% | 100.0% | -172.7% | 100.0% | 85.9% | -15.3% | – | -423.8% | |
| – | – | – | – | 376.7% | 278.7% | 339.5% | 232.3% | 272.7% | 97.9% | 1,538.3% | 93.1% | – | 6,218.0% | |
| – | – | – | – | 149.8% | 106.0% | 115.3% | 71.7% | 92.7% | 47.8% | 985.7% | 61.3% | – | 4,962.7% | |
| – | – | – | – | 526.5% | 384.7% | 454.8% | 308.3% | 92.7% | 144.5% | 2,524.0% | 139.1% | – | 11,486.3% | |
| – | – | – | – | -426.5% | -284.7% | -354.8% | -208.3% | -265.3% | -44.5% | -2,524.0% | -154.4% | – | -11,910.1% | |
| – | – | – | – | 4.5% | 5.0% | 4.1% | 1.5% | 8.8% | 2.0% | 84.5% | 10.4% | – | 0.0% | |
| – | – | – | – | -420.7% | -278.4% | -350.0% | -203.7% | -268.3% | -45.2% | -2,575.5% | -150.5% | – | 721.9% | |
| – | – | – | – | 10.2% | -5.0% | 4.7% | -17.5% | -8.0% | -2.8% | 51.4% | 11.8% | – | – | |
| – | – | – | – | -420.7% | -278.4% | -350.0% | -203.7% | -268.3% | -45.2% | -3,509.5% | -90.0% | – | 721.9% | |
| – | – | – | – | -407.2% | -255.8% | -327.0% | -180.2% | -232.8% | -39.1% | -2,398.0% | -143.6% | – | 1,245.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.